Justin Gunn

Justin Gunn is an experienced pharmaceutical executive currently serving as Vice President of Sales and Commercial Learning in Oncology at Corcept Therapeutics since July 2024. Prior to this role, Justin spent over 17 years at Gilead Sciences, where responsibilities included Executive Director positions in Sales for Gilead Oncology and HCV, as well as a Senior Sales Director role that involved the commercial launch in various therapeutic areas such as Pulmonary Arterial Hypertension and Hepatitis C. Earlier career experiences include National Sales Director and Regional Sales Director positions at Sepracor Inc, and roles in marketing and sales management at Merck. Justin holds a Bachelor of Science degree in Finance and Financial Management Services from the University of Arkansas.